Agenus (AGEN) FCF Margin (2010 - 2026)

Agenus' (AGEN) quarterly FCF Margin came in at 106.56% in Q1 2026, down 9.0% year-on-year from 117.1% in Q1 2025, and down 119.33% quarter-over-quarter from 48.58% in Q4 2025.

Agenus (AGEN) FCF Margin (2010 - 2026) Analysis & Trends

Agenus' FCF Margin history runs 17 years deep, the most recent figure standing at 106.56% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 9.0% year-over-year to 106.56% in Q1 2026; TTM through Mar 2026 was 70.66%, a 7632.0% increase from a year earlier, with the FY2025 full-year figure at 67.6%, up 8597.0% from the prior year.
  • FCF Margin eased to 106.56% in Q1 2026 per AGEN's latest filing, from 48.58% in the prior quarter.
  • Across five years, FCF Margin topped out at 97.82% in Q4 2022 and bottomed at 282.48% in Q3 2023.
  • The 5-year median for FCF Margin is 132.54% (2022), against an average of 138.19%.
  • Biggest YoY gain for FCF Margin was 30255 bps in 2022; the steepest drop was 18407 bps in 2022.
  • Year by year, FCF Margin stood at 97.82% in 2022, then slumped by 150 bps to 48.48% in 2023, then plunged by 121 bps to 107.04% in 2024, then jumped by 55 bps to 48.58% in 2025, then plunged by 119 bps to 106.56% in 2026.
  • Per Business Quant, the three latest AGEN FCF Margin figures stand at 106.56% (Q1 2026), 48.58% (Q4 2025), and 48.74% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn -106.56%

Historic Data

Download Data
DateValue
Mar 31, 2026 -106.56%
Dec 31, 2025 -48.58%
Sep 30, 2025 -48.74%
Jun 30, 2025 -78.72%
Mar 31, 2025 -106.47%
Dec 31, 2024 -107.04%
Sep 30, 2024 -212.25%
Jun 30, 2024 -164.37%
Mar 31, 2024 -136.50%
Dec 31, 2023 -48.48%
Sep 30, 2023 -282.48%
Jun 30, 2023 -254.90%
Mar 31, 2023 -263.59%
Dec 31, 2022 97.82%
Sep 30, 2022 -132.54%
Jun 30, 2022 -236.38%
Mar 31, 2022 -219.48%
Dec 31, 2021 -122.45%
Sep 30, 2021 51.53%
Jun 30, 2021 -538.93%